Go Pro
OTCMKTS:TINLY

Teijin Q1 2027 Earnings Report

Teijin logo
$10.45 0.00 (0.00%)
As of 10/2/2026

Teijin EPS Results

Actual EPS
$1.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Teijin Revenue Results

Actual Revenue
$1.39 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Teijin Announcement Details

Quarter
Q1 2027
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Teijin's next earnings date is estimated for Monday, November 9, 2026, based on past reporting schedules.

Conference Call Resources

Teijin Earnings Headlines

Teijin (TINLF) Receives a Hold from SMBC Nikko
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
See More Teijin Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Teijin? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teijin and other key companies, straight to your email.

About Teijin

Teijin (OTCMKTS:TINLY) Limited is a Japan-based technology-driven company whose businesses span advanced materials, fibers and healthcare. Its materials operations develop and manufacture products such as carbon fiber and aramid fibers, resin and composite materials, films, and other high-performance materials used in aerospace, automotive, electronics, construction, and industrial applications.

Through its healthcare business, Teijin provides pharmaceutical products and medical devices, including treatments for respiratory conditions and home healthcare services. The company also develops solutions related to sleep apnea, oxygen therapy, and other areas of chronic disease management.

Founded in Japan in 1918, Teijin has expanded its operations internationally and serves customers across Japan, Asia, Europe, North America, and other global markets. The company combines materials science, healthcare expertise, and information technology to develop products and services focused on sustainability, mobility, and improved quality of life.

View Teijin Profile